NCT02141152View on ClinicalTrials.gov

Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model

CompletedOBSERVATIONAL

Enrollment

895

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Metastatic Cancer

Trial Locations (1)

99999

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT02141152 - Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model | Biotech Hunter | Biotech Hunter